| RS115035890 |
DOCK6
|
Health Risk |
Conflicting classifications of pathogenicity |
DOCK6-related disorder, DOCK6-related disorder |
| RS115041708 |
RIPK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS115042043 |
LOXHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS115042730 |
INVS
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Infantile nephronophthisis |
| RS115046538 |
STX16
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudohypoparathyroidism type 1B, Inborn genetic diseases |
| RS115047866 |
MRPS7
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation deficiency 34, See cases |
| RS115049252 |
MTHFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Inborn genetic diseases |
| RS115052399 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS115063639 |
HSD17B3
|
Health Risk |
Pathogenic/Likely pathogenic |
Testosterone 17-beta-dehydrogenase deficiency, Testosterone 17-beta-dehydrogenase deficiency |
| RS115065523 |
CENPE
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS115065877 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS115066564 |
CACNA1D
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, CACNA1D-related disorder |
| RS115072194 |
NEFH
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, NEFH-related disorder |
| RS115073082 |
COG7
|
Health Risk |
Conflicting classifications of pathogenicity |
COG7 congenital disorder of glycosylation, COG7-related disorder |
| RS115074675 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS115076370 |
PARD3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS115079861 |
RMND1
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined oxidative phosphorylation defect type 11, Mitochondrial disease |
| RS115099192 |
GATA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Tetralogy of Fallot, Ventricular septal defect 1 |
| RS115108794 |
P3H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type 8, Osteogenesis Imperfecta |
| RS115109161 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS115109291 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Inborn genetic diseases |
| RS115111282 |
SLC26A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Achondrogenesis, type IB |
| RS115113440 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1D, Autosomal recessive nonsyndromic hearing loss 12 |
| RS115116398 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS115119858 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS115120891 |
KCNJ10
|
Health Risk |
Conflicting classifications of pathogenicity |
EAST syndrome, Autosomal recessive nonsyndromic hearing loss 4 |
| RS115126975 |
GABRG2
|
Health Risk |
Conflicting classifications of pathogenicity |
EPILEPSY, CHILDHOOD ABSENCE |
| RS115129687 |
BCHE
|
Health Risk |
Pathogenic |
Deficiency of butyrylcholinesterase, Deficiency of butyrylcholinesterase |
| RS115130936 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS115144373 |
ESCO2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Roberts-SC phocomelia syndrome |
| RS115145637 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS115149211 |
FREM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS115150240 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS115153488 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fibromatosis, gingival |
| RS115155458 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS115155934 |
FKTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1X, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS115156486 |
SETD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Luscan-Lumish syndrome, Inborn genetic diseases |
| RS115164694 |
TNFRSF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
TNF receptor-associated periodic fever syndrome (TRAPS), Autoinflammatory syndrome |
| RS115169993 |
DDR2
|
Health Risk |
Conflicting classifications of pathogenicity |
DDR2-related disorder, Warburg-cinotti syndrome |
| RS115184652 |
MEGF10
|
Health Risk |
Conflicting classifications of pathogenicity |
MEGF10-related myopathy, MEGF10-related disorder |
| RS115193744 |
GATAD2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome, Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome |
| RS115193764 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Carcinoma of colon |
| RS115195927 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS115195998 |
TMEM67
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS115198029 |
CRTAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta |
| RS115198308 |
PHYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Phytanic acid storage disease, Phytanic acid storage disease |
| RS115198722 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 4 |
| RS115199093 |
PLOD2
|
Health Risk |
Conflicting classifications of pathogenicity |
PLOD2-related disorder, PLOD2-related disorder |
| RS115199914 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, Iodotyrosyl coupling defect |
| RS115200412 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS115203053 |
ACO2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, ACO2-related disorder |
| RS115206553 |
DGUOK
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), DGUOK-related disorder |
| RS115209243 |
PIGC
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycosylphosphatidylinositol biosynthesis defect 16, Glycosylphosphatidylinositol biosynthesis defect 16 |
| RS115209326 |
FNIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Uterine corpus endometrial carcinoma, Familial cancer of breast |
| RS115212523 |
EPCAM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS115220304 |
RFXANK
|
Health Risk |
Conflicting classifications of pathogenicity |
MHC class II deficiency, RFXANK-related disorder |
| RS115223836 |
TMPRSS3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS115226995 |
TFAP2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, TFAP2B-related disorder |
| RS115227204 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS115230292 |
UTRN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS115230894 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia 1 |
| RS115231482 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial infantile |
| RS115238711 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 11, Usher syndrome type 1 |
| RS115239207 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS115246141 |
CNGB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Achromatopsia 3, Severe early-childhood-onset retinal dystrophy |
| RS115246424 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS115248068 |
ANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spherocytosis, Hereditary spherocytosis type 1 |
| RS115252223 |
PKD2L1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS115259839 |
PNKP
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 12 |
| RS115260724 |
P2RX2
|
Health Risk |
Conflicting classifications of pathogenicity |
P2RX2-related disorder, P2RX2-related disorder |
| RS115263899 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, Iodotyrosyl coupling defect |
| RS115265574 |
HPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 1, Hermansky-Pudlak syndrome |
| RS115272158 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS115272639 |
NPHP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Nephronophthisis |
| RS115273369 |
KCNMA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy-paroxysmal dyskinesia syndrome, KCNMA1-related disorder |
| RS115275492 |
LOXHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS115282473 |
SLC6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Parkinsonism-dystonia, infantile |
| RS115282699 |
HOGA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS115286894 |
ROS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS115287026 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, ALPK3-related disorder |
| RS115295826 |
SI
|
Health Risk |
Conflicting classifications of pathogenicity |
Sucrase-isomaltase deficiency, Sucrase-isomaltase deficiency |
| RS115297652 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS115298512 |
CFHR4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS115298665 |
WRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Werner syndrome, WRN-related disorder |
| RS115299174 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS115299472 |
DNAI2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 9 |
| RS115303497 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS115308424 |
NPHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS115310278 |
DUOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid dyshormonogenesis 6, Thyroid dyshormonogenesis 6 |
| RS115317386 |
LCA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS115320113 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS115321388 |
DNAH7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS115324411 |
INVS
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Inborn genetic diseases |
| RS115327470 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS115328026 |
MCCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylcrotonyl-CoA carboxylase 2 deficiency, MCCC2-related disorder |
| RS115328064 |
BBS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 2 |
| RS115330112 |
LYST
|
Health Risk |
Conflicting classifications of pathogenicity |
Chédiak-Higashi syndrome, Autoinflammatory syndrome |
| RS115333628 |
NPHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS115344041 |
PMM2
|
Health Risk |
Conflicting classifications of pathogenicity |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS115347084 |
RUNX2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |